NUCANA BIOMED
NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally designed medicines that address significant unmet medical needs. Our management team has extensive experience of building successful biopharmaceutical companies. This includes the formation and subsequent growth of Bioenvision into a NASDAQ National listed, global biopharmaceutical company, which was acquired by Genzyme Corporation in October 2007. Speci... fic management expertise includes the development, approval and commercialisation of oncology medicines. We are developing a portfolio of first-in-class and best-in-class pharmaceutical products designed to treat life-threatening or debilitating diseases. Our primary focus is in the area of oncology, although our technology platform has broader clinical potential.
NUCANA BIOMED
Industry:
Biotechnology Medical Therapeutics
Founded:
1997-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nucanabiomed.com
Total Employee:
11+
Status:
Active
Contact:
44 13 1248 3660
Email Addresses:
[email protected]
Total Funding:
247.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Synosia Therapeutics
Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Abingworth
Abingworth investment in Post-IPO Equity - NuCana BioMed
Sofinnova Investments
Sofinnova Investments investment in Series B - NuCana BioMed
Scottish Investment Bank
Scottish Investment Bank investment in Series B - NuCana BioMed
Sofinnova Partners
Sofinnova Partners investment in Series A - NuCana BioMed
Scottish Enterprise
Scottish Enterprise investment in Series A - NuCana BioMed
Morningside Group
Morningside Group investment in Series A - NuCana BioMed
Official Site Inspections
http://www.nucanabiomed.com
- Host name: toad.exacthosting.com
- IP address: 50.28.1.55
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "NuCana BioMed"
NuCana plc - ProTide technology to transform some of the most …
We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we …See details»
NuCana BioMed - Crunchbase Company Profile
NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally …See details»
NuCana plc - ProTide technology to transform some of …
NuCana plc - ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents. Our name "NuCana" is derived from "New Cancer Agents”. It represents our goal of inventing, developing and …See details»
NuCana Company Profile 2024: Stock Performance & Earnings
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is …See details»
NuCana plc (NCNA) Company Profile & Facts - Yahoo Finance
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed...See details»
NuCana plc - ProTide technology to transform some of the most …
Our. Pioneering Approach. We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. We apply our ProTide …See details»
NuCana plc - LinkedIn
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform...See details»
NuCana plc (NCNA) Company Profile & Overview - Stock Analysis
Nov 21, 2024 · NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to …See details»
Organization | Nucana
Organization Overview. First Clinical Trial. 2012 NCT01621854. First Marketed Drug. None First NDA Approval. None ... NuCana Biomed | NuCana BioMed Ltd. | NuCana plc Active …See details»
NuCana plc - ProTide technology to transform some of the most …
NuCana plc - ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents. News & Events. November 2024. NuCana Announces Encouraging Initial …See details»
NuCana - Biotech Careers
Nucana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying phosphoramidate chemistry …See details»
NuCana plc - LinkedIn
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry …See details»
NuCana BioMed - Funding, Financials, Valuation & Investors
Sep 28, 2020 · NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.See details»
NuCana Plc
Our ProTide Solution. Limitations of Existing. Nucleoside Analogs. Nucleoside analogs are some of the most widely prescribed chemotherapy agents. They block the replication of cancer cells …See details»
NuCana BioMed - Contacts, Employees, Board Members
NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.See details»
NuCana BioMed - Products, Competitors, Financials, Employees ...
NuCana BioMed is a clinical-stage biopharmaceutical company with a focus on oncology. The company's main service is the development of more effective and safer medicines for cancer …See details»
NuCana BioMed Secures $10.4 Million Series A Financing to …
NuCana BioMed (“Nucana”), a biopharmaceutical company specialising in developing the next generation of anti-cancer therapies, today announced it had secured £6.74 million ($10.4 …See details»
Ian Abercrombie - Business Unit Director & Chief Operating …
Ian Abercrombie has 2 current jobs as Chief Executive Officer at Medannex and Business Unit Director & Chief Operating Officer at NuCana BioMed. Additionally, Ian Abercrombie has had …See details»
NuCana BioMed Secures $10.4 Million Series A Financing
Nov 29, 2011 · NuCana BioMed ("Nucana"), a biopharmaceutical company specialising in developing the next generation of anti-cancer therapies, today announced it had secured …See details»